Phase 3 Study to Evaluate the Efficacy & Safety of Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma.

Condition:   Asthma Interventions:   Biological: Experimental: Tezepelumab;   Other: Placebo Sponsors:   AstraZeneca;   Amgen Not yet recruiting

Source: ClinicalTrials.gov - November 20, 2017 Category: Research Source Type: clinical trials